SCHEMBL8068381

SCHEMBL8068381

CCOP(=O)(OCC)OC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 9/20 0.54
▸ CYP3A4 P08684 5/20 0.54
▸ PGR P06401 5/20 0.54
▸ AR P10275 4/20 0.54
▸ USP2 O75604 1/20 0.54
▸ HIF1A Q16665 6/20 0.51
▸ LMNA P02545 5/20 0.51
▸ MAPT P10636 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ABCB11 O95342 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ NR1I2 O75469 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8068358 0.87 NR3C1 (0.60) NR3C1CYP3A4PGRARUSP2
SCHEMBL7080634 0.86 NR3C1 (0.62) NR3C1CYP3A4PGRARUSP2
SCHEMBL8672115 0.85 NR3C1 (0.72) NR3C1CYP3A4PGRARHIF1A
SCHEMBL4734726 0.84 NR3C1 (0.70) NR3C1CYP3A4PGRARUSP2
SCHEMBL7905893 0.83 NR3C1 (0.58) NR3C1CYP3A4PGRARUSP2
SCHEMBL11682502 0.82 NR3C1 (0.58) NR3C1CYP3A4PGRARUSP2
SCHEMBL4734156 0.82 NR3C1 (0.72) NR3C1CYP3A4PGRARUSP2
SCHEMBL11682563 0.82 NR3C1 (0.59) NR3C1CYP3A4PGRARUSP2
SCHEMBL8204332 0.81 NR3C1 (0.59) NR3C1CYP3A4PGRARUSP2
SCHEMBL11682590 0.81 NR3C1 (0.58) NR3C1CYP3A4PGRARUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6114318-A ANTIINFLAMMATORY AGENT, ANTIALLERGENS GLAXO GROUP LIMITED (GB) 2000-09-05 — — US disclosed
EP-0883628-B1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LTD (GB) 2000-08-16 — — EP disclosed
EP-0883628-A1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LIMITED (GB) 1998-12-16 — — EP disclosed
WO-1997024368-A1 17BETA-(2-OXO-TETRAHYDROFURAN-4-YL)-THIO-ANDROSTANE DERIVATIVES (17BETA-(GAMMA-BUTYRIC ACID LACTONE)-THIO DERIVATIVES) FOR THE TREATMENT OF INFLAMMATION AND PHARMACEUTICAL COMPOSITIONS AND A PROCESS FOR THE PRODUCTION THEREOF GLAXO GROUP LIMITED (GB) 1997-07-10 — — WO disclosed
Send feedback